| Mar 1 2023 |
When A High Rating Is Not Good |
Nelson Mullins |
| Mar 1 2023 |
California Law May Limit Hospitals’ Ability to Adopt The Joint Commission’s Revised Reappointment Timeframe Standards |
ArentFox Schiff LLP |
| Feb 28 2023 |
Proposed Nursing Home Disclosure Requirements Target Private Equity Companies and REITs |
ArentFox Schiff LLP |
| Feb 28 2023 |
Recent FTC Enforcement Action Merits Cyber Insurance Coverage Review |
Hunton Andrews Kurth |
| Feb 28 2023 |
CMS Updates List of Telehealth Services for CY 2023 |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 28 2023 |
Health Plans’ Gag Clause Attestations Due December 31, 2023 |
Foley & Lardner LLP |
| Feb 28 2023 |
This Week in 340B: February 21 – 27, 2023 |
McDermott Will & Schulte LLP |
| Feb 27 2023 |
Old North State Report – Feb. 27, 2023 |
Nelson Mullins |
| Feb 27 2023 |
CMS Issues Proposed Rule Requiring Nursing Homes to Disclose Additional Ownership Information, Including Ties to Private Equity and REITS |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 27 2023 |
Multiple Concussions Result in Greater Cognitive Deficits |
Stark & Stark |
| Feb 27 2023 |
USPTO Launches Cancer Moonshot Expedited Examination Pilot Program |
Foley & Lardner LLP |
| Feb 27 2023 |
Challenges to the No Surprises Act Continue: The Latest includes a Challenge to a 600% Increase in Administrative Fees |
Proskauer Rose LLP |
| Feb 27 2023 |
Navigating Permissive State Laws in Light of the Federal Information Blocking Rules |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 27 2023 |
Tick-Tock – Time for Healthcare Employers to Review Their Internet and Social Media Use Policies! |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 27 2023 |
DEA Announces Permanent Flexibilities for the Prescribing of Controlled Substances via Telemedicine |
Polsinelli PC |
| Feb 27 2023 |
China on the Move: Lesson from China’s National Negotiation of Drug Prices in 2022 |
Greenberg Traurig, LLP |
| Feb 27 2023 |
DEA’s Proposed Rules on Telemedicine Controlled Substances Prescribing after the PHE Ends |
Foley & Lardner LLP |
| Feb 25 2023 |
CES 2023 Highlights – Technology Continues to Shine |
Foley & Lardner LLP |
| Feb 25 2023 |
No Surprises Act Update: Certified IDR Entities to Resume Payment Determinations for Services Furnished Before October 25, 2022 |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 25 2023 |
HHS-OIG Declines to Impose Sanctions on Drug Manufacturer for Financial Assistance to Pediatric Patients with Rare Disease |
Barnes & Thornburg LLP |
| Feb 24 2023 |
Sport-Related Concussion in Female Athletes: A Systematic Review |
Stark & Stark |
| Feb 24 2023 |
CMS Plans to Implement Stricter Enforcement Efforts to Boost Hospital Price Transparency Compliance |
Squire Patton Boggs (US) LLP |
| Feb 24 2023 |
How Employers Should Prepare for the End of the Covid-19 National and Public Health Emergencies |
McDermott Will & Schulte LLP |
| Feb 24 2023 |
Bloomington and St. Paul’s Sick and Safe Time Ordinances Get Checkups in the New Year |
Jackson Lewis P.C. |
| Feb 24 2023 |
High Screening May Lead to High Stakes for SNFs |
Nelson Mullins |
| Feb 24 2023 |
Annual Breach Notification Deadline to OCR Looming |
Robinson & Cole LLP |
| Feb 23 2023 |
HHS Announces Record Number of ACA Marketplace Enrollments |
McDermott Will & Schulte LLP |
| Feb 23 2023 |
Specific Language Not Required in New Jersey Arbitration Agreements Between Sophisticated Parties |
K&L Gates LLP |
| Feb 23 2023 |
Podcast: Direct Access Laboratory Testing: Navigating the Regulatory Landscape – Diagnosing Health Care [VIDEO] |
Epstein Becker & Green, P.C. |
| Feb 23 2023 |
Modified REMS, Clarification on Mailing Drugs, and Movement in Texas Case Mark Significant Weeks in the Reproductive Health Legal Sphere |
ArentFox Schiff LLP |
| Feb 23 2023 |
HGPII Details GPOs’ Efforts to Reduce Prices and Increase Transparency Amid Marketplace Challenges |
ArentFox Schiff LLP |
| Feb 23 2023 |
Federal Circuit Weighs In On Patent Eligibility Of Isolated Vitamin |
Foley & Lardner LLP |
| Feb 22 2023 |
CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 22 2023 |
Physician Practice Transactions: NY’s Proposed Review and Monitoring Increases Visibility and Adds Deal Risk |
Foley & Lardner LLP |
| Feb 22 2023 |
HIPAA Breaches and Compliance: Key Findings & Lessons Learned from OCR’s Reports to Congress |
Foley & Lardner LLP |
